pravastatin has been researched along with HIV-Associated Lipodystrophy Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloch, M; Calmy, A; Carr, A; Cooper, DA; Delhumeau, C; Finlayson, R; Hirschel, B; Norris, R; Rafferty, M; Wand, H | 1 |
| Carr, A; Cooper, DA; Feneley, MP; Kent-Hughes, J; Kovacic, JC; Mallon, PW; Miller, J; Norris, R; Samaras, K | 1 |
| Boccara, F; Capeau, J; Gharakhanian, S | 1 |
2 trial(s) available for pravastatin and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.
Topics: Absorptiometry, Photon; Adiposity; Adult; Anti-Retroviral Agents; Anticholesteremic Agents; Dideoxynucleosides; Drug Therapy, Combination; Extremities; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lopinavir; Male; Middle Aged; Pravastatin; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Uridine | 2010 |
Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
Topics: Adipose Tissue; Antiretroviral Therapy, Highly Active; Biomarkers; Blood Glucose; Body Composition; Cardiovascular Diseases; Cholesterol; Diet; Double-Blind Method; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin; Male; Middle Aged; Pilot Projects; Pravastatin; Triglycerides | 2006 |
1 other study(ies) available for pravastatin and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Statins in HIV-associated lipodystrophy and metabolic syndrome: is there a missing link?
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Pravastatin; Treatment Outcome | 2006 |